We subsequently exposed all control and AD iNs to 0.3 μM ABT-737, which resulted in 3- and 5-fold increases in Casp3 staining in control and AD iNs, respectively (Figures 6E and 6F). Here, CASP3 is linked to Alzheimer disease.